Evaluating Therapeutic Equivalence of Generic and Original Levetiracetam in Patients with Epilepsy: A Retrospective Study

Evaluating Therapeutic Equivalence of Generic and Original Levetiracetam in Patients with Epilepsy: A Retrospective Study

The brand interchangeability of antiepileptic drugs (AEDs) is a topic of debate, especially regarding their therapeutic equivalence. This study evaluates the efficacy and tolerability of generic levetiracetam compared to the brand-name equivalent in a routine clinical setting. We conducted a retrosp...

Full description

Bibliographic Details
Main Authors:	Jannapas Tharavichitkun, Tinonkorn Yadee, Poomchai Angkaow, Thanarat Suansanae
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Neurology International
Subjects:	epilepsy seizure therapeutic equivalence generic substitution levetiracetam
Online Access:	https://www.mdpi.com/2035-8377/14/1/22

Similar Items

Anti-seizures therapeutics in patients with epilepsy: an approach to levetiracetam – review
by: Barbara Rusinowska
Published: (2022-08-01)

Levetiracetam – epilepsy treatment, pharmacokinetics, mechanism of action, interaction and toxicity
by: Piotr Kozłowski, et al.
Published: (2015-04-01)

Levetiracetam – epilepsy treatment, pharmacokinetics, mechanism of action, interaction and toxicity
by: Piotr Kozłowski, et al.
Published: (2015-04-01)

Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force
by: Jenna Niyongere, et al.
Published: (2022-06-01)

Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
by: Maria Luiza Giraldes de MANREZA, et al.
Published: (2021-06-01)

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles
by: Yi ZM, et al.
Published: (2018-12-01)

Clinical Pharmacology and Pharmacokinetics of Levetiracetam
by: Chanin Clark Wright, et al.
Published: (2013-12-01)

Pregabalin Add-On vs. Dose Increase in Levetiracetam Add-On Treatment: A Real-Life Trial in Dogs With Drug-Resistant Epilepsy
by: Sandra R. P. Kriechbaumer, et al.
Published: (2022-07-01)

Efficacy and Tolerability of Intravenous Levetiracetam in Children
by: Jose eAceves, et al.
Published: (2013-08-01)

Behavioral Changes Under Levetiracetam Treatment in Dogs
by: Johannes Roland Erath, et al.
Published: (2020-04-01)

Role of Intravenous Levetiracetam in Acute Seizure Management
by: BATOOL F. KIRMANI
Published: (2014-06-01)

Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database
by: Kensuke Nakamura, et al.
Published: (2020-07-01)

Comparative Efficacy of Levetiracetam for Epilepsy in School-Aged Children with Intellectual Disability and Normal Intelligence
by: Ja Un Moon, et al.
Published: (2021-10-01)

Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial
by: Kensuke Nakamura, et al.
Published: (2021-05-01)

Efficacy of Levetiracetam Monotherapy in Childhood Epilepsy
by: Müjgan ARSLAN, et al.
Published: (2017-04-01)

Stuttering Priapism Associated with Levetiracetam
by: Mehmet Taylan PEKÖZ, et al.
Published: (2018-08-01)

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

Neurobehavioral Effects of Levetiracetam in Brain Tumor Related Epilepsy
by: Abigail eBernett, et al.
Published: (2013-07-01)

Levetiracetam effectiveness as add-on therapy in Bulgarian patients with drug-resistant epilepsy
by: Ekaterina I. Viteva, et al.
Published: (2021-04-01)

Antimyoclonic Effect of Levetiracetam and Clonazepam Combined Treatment on Myoclonic Epilepsy with Ragged-Red Fiber Syndrome with m.8344A>G Mutation
by: Li-Jun Su, et al.
Published: (2018-01-01)

Role of Intravenous Levetiracetam in Seizure Prophylaxis of Severe Traumatic Brain Injury Patients
by: BATOOL F. KIRMANI, et al.
Published: (2013-11-01)

Phenytoin Versus Levetiracetam for Post-traumatic Seizure Prophylaxis
by: Tuğçe Mengi, et al.
Published: (2022-12-01)

Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy
by: El Sabaa RM, et al.
Published: (2020-08-01)

Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy
by: Etsuko Yamamoto Hattori, et al.
Published: (2023-09-01)

A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy
by: Zhang LL, et al.
Published: (2018-03-01)

A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy
by: Chen D, et al.
Published: (2019-04-01)

Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model
by: Iván Ignacio-Mejía, et al.
Published: (2023-03-01)

Levetiracetam and lamotrigine in old aged onset of epilepsy: a randomized double-blind clinical trial
by: Mahmood Motamedi, et al.
Published: (2013-12-01)

Hematological and Renal Effects of Levetiracetam Versus Lamotrigine in Children With Epilepsy: A Randomized Clinical Trial
by: Maryam Esteghamati, et al.
Published: (2022-07-01)

Evaluation of the Effect of Levetiracetam Monotherapy in Comparison with Sodium Valproate in the Treatment of Children with Generalized or Focal Epilepsy in a Randomized Clinical Trial
by: Afshin Fayazi, et al.
Published: (2021-09-01)

Efficacy of generic levetiracetam (epiterra) in monotherapy for epilepsy in adult patients: preliminary results
by: V. A. Karlov, et al.
Published: (2015-03-01)

Efficacy of levetiracetam for neonatal seizures in preterm infants
by: Ji Yoon Han, et al.
Published: (2018-04-01)

Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
by: Sanjeev Kharel, et al.
Published: (2022-11-01)

Levetiracetam and N-Cadherin Antibody Alleviate Brain Pathology Without Reducing Early Epilepsy Development After Focal Non-convulsive Status Epilepticus in Rats
by: Una Avdic, et al.
Published: (2021-02-01)

Effects of Levetiracetam on the Serum C-Reactive Protein in Children With Epilepsy: A Meta-Analysis
by: You-Feng Zhou, et al.
Published: (2022-04-01)

Once-Daily Extended-Release Levetiracetam Improves Medication Compliance in Adolescent Epilepsy Patients
by: Seung Yeon Jung, et al.
Published: (2021-04-01)

Long-term levetiracetam monotherapy for partial epilepsy in adults
by: P. N. Vlasov, et al.
Published: (2014-01-01)

Effect of levetiracetam and valproate on late-onset post-traumatic seizures
by: Yanli Wang, et al.
Published: (2023-04-01)

An open-label prospective clinical study of the efficacy and tolerability of brand-name and generic levetiracetam in the monotherapy of focal epilepsy in adults
by: V. A. Karlov, et al.
Published: (2018-07-01)

Clinical features and treatment outcomes of Juvenile myoclonic epilepsy patients
by: Yingying Zhang, et al.
Published: (2019-06-01)